Literature DB >> 15228098

Losartan reverses fibrotic changes in cortical renal tissue induced by ischemia or ischemia-reperfusion without changes in renal function.

Andrés Barrilli1, Sara Molinas, Guillermo Petrini, Mauricio Menacho, María Mónica Elías.   

Abstract

Unilateral renal ischemia for 40 min in rat results in increased fibronectin (FN) expression in proximal tubular cells. This study examines the role of 24 h of blood reperfusion and the role of the renin-angiotensin system (RAS) on these results. Rats were submitted to 40 min of unilateral renal ischemia followed by 24 h of blood reperfusion. Renal function was assayed by clearance measurement in metabolic cages. Intracellular ATP and calcium were determined in proximal tubules. The expression and abundance of FN were investigated by reverse transcription-polymerase chain reaction, ELISA and Western blot either in isolated proximal tubules or cortex homogenates from control, ischemic and ischemic with reperfusion rats. Matrix metalloproteases (MMPs) activity was also measured. Losartan effects on renal function and on the abundance of FN and the MMPs activity in cortical homogenates were also measured. The renal function remained altered after 24 h of reperfusion in untreated and losartan-treated ischemic rats. On the other hand, the abundance of FN is increased after reperfusion both in isolated proximal tubules and total cortex homogenates and the same pattern was observed in the MMPs activity. Twenty-four h of blood reperfusion presented FN-mRNA signals similar to control ones. Losartan pretreated-rats presented diminished FN abundance in homogenates of cortex tissue from ischemic rats with or without reperfusion. Similar results were observed in the MMPs-activity. These results suggest that angiotensin II acting via the AT1 receptor plays a role in the development of tubulointersticial fibrosis after ischemia-reperfusion by activation of intrarenal RAS from the injured kidney.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15228098     DOI: 10.1023/b:mcbi.0000026068.38301.cf

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  54 in total

1.  Enhancement of glomerular mesangial cell neutral proteinase secretion by macrophages: role of interleukin 1.

Authors:  J Martin; D H Lovett; D Gemsa; R B Sterzel; M Davies
Journal:  J Immunol       Date:  1986-07-15       Impact factor: 5.422

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Phosphatase activity along the nephron of mice with hypophosphatemic vitamin-D-resistant rickets.

Authors:  M G Brunette; M Chan; M Lebrun
Journal:  Kidney Int       Date:  1981-08       Impact factor: 10.612

4.  Ischemic acute renal failure induces differential expression of small heat shock proteins.

Authors:  William E Smoyer; Richard Ransom; Raymond C Harris; Michael J Welsh; Gudrun Lutsch; Rainer Benndorf
Journal:  J Am Soc Nephrol       Date:  2000-02       Impact factor: 10.121

5.  Role of AT1 angiotensin II receptors in renal ischemic injury.

Authors:  J Kontogiannis; K D Burns
Journal:  Am J Physiol       Date:  1998-01

6.  Angiotensin II type 1 receptor antagonist (losartan) down-regulates transforming growth factor-beta in experimental acute pyelonephritis.

Authors:  A Khalil; K Tullus; M Bakhiet; L G Burman; G Jaremko; A Brauner
Journal:  J Urol       Date:  2000-07       Impact factor: 7.450

7.  Targeting TGF-beta overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockade.

Authors:  H Peters; W A Border; N A Noble
Journal:  Kidney Int       Date:  1998-11       Impact factor: 10.612

8.  Fibronectin synthesis in tubular epithelial cells: up-regulation of the EDA splice variant by transforming growth factor beta.

Authors:  C Viedt; A Bürger; G M Hänsch
Journal:  Kidney Int       Date:  1995-12       Impact factor: 10.612

9.  Soluble latent membrane-type 1 matrix metalloprotease secreted by human mesangial cells is activated by urokinase.

Authors:  I Kazes; F Delarue; J Hagège; L Bouzhir-Sima; E Rondeau; J D Sraer; G Nguyen
Journal:  Kidney Int       Date:  1998-12       Impact factor: 10.612

10.  The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1.

Authors:  R V Ward; R M Hembry; J J Reynolds; G Murphy
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

View more
  6 in total

1.  Evolution of renal function and Na+, K +-ATPase expression during ischaemia-reperfusion injury in rat kidney.

Authors:  Sara M Molinas; Laura Trumper; Esteban Serra; M Mónica Elías
Journal:  Mol Cell Biochem       Date:  2006-05-13       Impact factor: 3.396

2.  Urinary Angiotensinogen: A Promising Biomarker of AKI Progression in Acute Decompensated Heart Failure: What Does It Mean?

Authors:  Jan Wysocki; Daniel Batlle
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-18       Impact factor: 8.237

3.  Association of elevated urinary concentration of renin-angiotensin system components and severe AKI.

Authors:  Joseph L Alge; Nithin Karakala; Benjamin A Neely; Michael G Janech; James A Tumlin; Lakhmir S Chawla; Andrew D Shaw; John M Arthur
Journal:  Clin J Am Soc Nephrol       Date:  2013-09-05       Impact factor: 8.237

Review 4.  Renal ischemia/reperfusion injury; from pathophysiology to treatment.

Authors:  Maryam Malek; Mehdi Nematbakhsh
Journal:  J Renal Inj Prev       Date:  2015-06-01

5.  Anti-Fibrotic Effect of Losartan, an Angiotensin II Receptor Blocker, Is Mediated through Inhibition of ER Stress via Up-Regulation of SIRT1, Followed by Induction of HO-1 and Thioredoxin.

Authors:  Hyosang Kim; Chung Hee Baek; Raymond Bok Lee; Jai Won Chang; Won Seok Yang; Sang Koo Lee
Journal:  Int J Mol Sci       Date:  2017-01-31       Impact factor: 5.923

6.  Urinary angiotensinogen predicts adverse outcomes among acute kidney injury patients in the intensive care unit.

Authors:  Joseph L Alge; Nithin Karakala; Benjamin A Neely; Michael G Janech; Juan Carlos Q Velez; John M Arthur
Journal:  Crit Care       Date:  2013-04-15       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.